Molecular Metabolism

Article	Citations
GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art	672
Dysregulated lipid metabolism links NAFLD to cardiovascular disease	256
Metabolic-associated fatty liver disease and lipoprotein metabolism	250
Diabetes, infection risk and COVID-19	227
GLP-1 physiology informs the pharmacotherapy of obesity	174
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans	174
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease	168
A guide to understanding endoplasmic reticulum stress in metabolic disorders	165
Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street	151
Role of NAD+ in regulating cellular and metabolic signaling pathways	139
The melanocortin pathway and energy homeostasis: From discovery to obesity therapy	129
Insulin-like growth factors: Ligands, binding proteins, and receptors	121
Hepatokines and metabolism: Deciphering communication from the liver	119
Insulin action at a molecular level – 100 years of progress	118
Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD	116
Metabolic drivers of non-alcoholic fatty liver disease	108
Imaging biomarkers of NAFLD, NASH, and fibrosis	103
The brain as an insulin-sensitive metabolic organ	98
Phosphoenolpyruvate carboxykinase in cell metabolism: Roles and mechanisms beyond gluconeogenesis	93
Genetic and epigenetic factors determining NAFLD risk	87
CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing	83
GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease	79
Single-cell transcriptomics of human islet ontogeny defines the molecular basis of β-cell dedifferentiation in T2D	73
Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis	73
Ferroptosis and ferritinophagy in diabetes complications	72

Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms	72
Nicotinamide N-methyltransferase: At the crossroads between cellular metabolism and epigenetic regulation	71
Understanding insulin and its receptor from their three-dimensional structures	67
Overexpression of the vitamin D receptor (VDR) induces skeletal muscle hypertrophy	64
Exploring the therapeutic potential of mitochondrial uncouplers in cancer	63
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment	63
Wnt/β-catenin signaling regulates adipose tissue lipogenesis and adipocyte-specific loss is rigorously defended by neighboring stromal-vascular cells	62
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice	61
Chronic inflammation and the hallmarks of aging	59
Mitochondrial oxidative function in NAFLD: Friend or foe?	59
Role and mechanism of ferroptosis in neurological diseases	58
Infusion of donor feces affects the gut–brain axis in humans with metabolic syndrome	58
Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH	56
Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload	55
Impacts of essential amino acids on energy balance	54
FGF19 and FGF21: In NASH we trust	51
Suppressing adipocyte inflammation promotes insulin resistance in mice	50
Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes	50
Spatiotemporal GLP-1 and GIP receptor signaling and trafficking/recycling dynamics induced by selected receptor mono- and dual-agonists	49
AhR activation defends gut barrier integrity against damage occurring in obesity	48
Sperm histone H3 lysine 4 tri-methylation serves as a metabolic sensor of paternal obesity and is associated with the inheritance of metabolic dysfunction	48
BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy	47
A survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing	47
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction	46
LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue	45
Maternal obesity causes fetal hypothalamic insulin resistance and disrupts development of hypothalamic feeding pathways	44
Loss of UCP1 function augments recruitment of futile lipid cycling for thermogenesis in murine brown fat	44
LKB1 deficiency-induced metabolic reprogramming in tumorigenesis and non-neoplastic diseases	43
Non-alcoholic fatty liver disease and steatohepatitis: State of the art on effective therapeutics based on the gold standard method for diagnosis	43
Vagal neuron expression of the microbiota-derived metabolite receptor, free fatty acid receptor (FFAR3), is necessary for normal feeding behavior	42
MicroRNAs in non-alcoholic fatty liver disease: Progress and perspectives	42
Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH	42
Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis	42
Organelle transporters and inter-organelle communication as drivers of metabolic regulation and cellular homeostasis	41
LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway	41
Testosterone metabolites differentially regulate obesogenesis and fat distribution	40
Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease	40
Dopamine D2 receptor agonist, bromocriptine, remodels adipose tissue dopaminergic signalling and upregulates catabolic pathways, improving metabolic profile in type 2 diabetes	40
Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high-fat diet	39
Cholesterol 25-hydroxylase (CH25H) as a promoter of adipose tissue inflammation in obesity and diabetes	38
Insulin's actions on vascular tissues: Physiological effects and pathophysiological contributions to vascular complications of diabetes	37
Update on the effects of energy metabolism in bone marrow mesenchymal stem cells differentiation	37
Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue	37
Hepatic FTO is dispensable for the regulation of metabolism but counteracts HCC development in vivo	37
Extracellular serine and glycine are required for mouse and human skeletal muscle stem and progenitor cell function	37
Exercise mitigates sleep-loss-induced changes in glucose tolerance, mitochondrial function, sarcoplasmic protein synthesis, and diurnal rhythms	36
Hypoxia-inducible lipid droplet-associated induces DGAT1 and promotes lipid storage in hepatocytes	36
Nampt controls skeletal muscle development by maintaining Ca2+ homeostasis and mitochondrial integrity	36
Adipocyte-specific Beclin1 deletion impairs lipolysis and mitochondrial integrity in adipose tissue	36
Inducible deletion of skeletal muscle AMPKα reveals that AMPK is required for nucleotide balance but dispensable for muscle glucose uptake and fat oxidation during exercise	35

CD81 marks immature and dedifferentiated pancreatic β-cells	35
Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical application	35
Cardiovascular protection by SGLT2 inhibitors – Do anti-inflammatory mechanisms play a role?	34
Microbiota and body weight control: Weight watchers within?	34
The hepatocyte IKK:NF-κB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis	34
The gut–brain axis: Identifying new therapeutic approaches for type 2 diabetes, obesity, and related disorders	34
Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease	34
Anorectic and aversive effects of GLP-1 receptor agonism are mediated by brainstem cholecystokinin neurons, and modulated by GIP receptor activation	34
Skeletal muscle undergoes fiber type metabolic switch without myosin heavy chain switch in response to defective fatty acid oxidation	33
Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice	33
Comparative analysis of oral and intraperitoneal glucose tolerance tests in mice	33
Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway	33
An accomplice more than a mere victim: The impact of β-cell ER stress on type 1 diabetes pathogenesis	33
Mitochondrial function in intestinal epithelium homeostasis and modulation in diet-induced obesity	33
Purification of pancreatic endocrine subsets reveals increased iron metabolism in beta cells	33
Tirzepatide induces a thermogenic-like amino acid signature in brown adipose tissue	32
Glucose-induced insulin secretion in isolated human islets: Does it truly reflect β-cell function in vivo?	32
Liver-specific Prkn knockout mice are more susceptible to diet-induced hepatic steatosis and insulin resistance	31
Growth differentiation factor 15 as a potential therapeutic for treating obesity	31
Parathyroid hormone (PTH) regulation of metabolic homeostasis: An old dog teaches us new tricks	31
Ovarian cancer modulates the immunosuppressive function of CD11b+Gr1+ myeloid cells via glutamine metabolism	31
NF-κB signaling in tanycytes mediates inflammation-induced anorexia	31
RNA m6A reader IMP2/IGF2BP2 promotes pancreatic β-cell proliferation and insulin secretion by enhancing PDX1 expression	31
p21 induces a senescence program and skeletal muscle dysfunction	31
Whole-brain activation signatures of weight-lowering drugs	30
Dpp4+ interstitial progenitor cells contribute to basal and high fat diet-induced adipogenesis	30
Review: Glucose-sensitive insulin	30
Time and metabolic state-dependent effects of GLP-1R agonists on NPY/AgRP and POMC neuronal activity in vivo	30
Active integrins regulate white adipose tissue insulin sensitivity and brown fat thermogenesis	30
Prior exercise in humans redistributes intramuscular GLUT4 and enhances insulin-stimulated sarcolemmal and endosomal GLUT4 translocation	30
ATF4-mediated transcriptional regulation protects against β-cell loss during endoplasmic reticulum stress in a mouse model	30
Reappraisal of the optimal fasting time for insulin tolerance tests in mice	30
Metformin-induced reductions in tumor growth involves modulation of the gut microbiome	29
Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease	29
Toward modeling metabolic state from single-cell transcriptomics	29
Exercise training reverses cancer-induced oxidative stress and decrease in muscle COPS2/TRIP15/ALIEN	29
Early induction of hepatic deiodinase type 1 inhibits hepatosteatosis during NAFLD progression	29
Gut microbiota impairs insulin clearance in obese mice	29
Ceramides are necessary and sufficient for diet-induced impairment of thermogenic adipocytes	29
SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans	29
A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression	29
Increased glycolysis affects β-cell function and identity in aging and diabetes	28
Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent	28
Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis	28
New dawn for cancer cell death: Emerging role of lipid metabolism	28
Serum integrative omics reveals the landscape of human diabetic kidney disease	28
“A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes”	27
Novel noncoding RNA CircPTK2 regulates lipolysis and adipogenesis in cachexia	27
Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression	27
Stress kinases in the development of liver steatosis and hepatocellular carcinoma	27
P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response	27
Metabolic insights from a GHSR-A203E mutant mouse model	27
Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states	27
Day-night rhythm of skeletal muscle metabolism is disturbed in older, metabolically compromised individuals	26
Glucocorticoids coordinate macrophage metabolism through the regulation of the tricarboxylic acid cycle	26
Aster-B coordinates with Arf1 to regulate mitochondrial cholesterol transport	26
β-catenin regulates muscle glucose transport via actin remodelling and M-cadherin binding	26
Mitochondrial AIF loss causes metabolic reprogramming, caspase-independent cell death blockade, embryonic lethality, and perinatal hydrocephalus	26
Extensive NEUROG3 occupancy in the human pancreatic endocrine gene regulatory network	26
Peroxisomal regulation of energy homeostasis: Effect on obesity and related metabolic disorders	26
Tryptophan metabolism is a physiological integrator regulating circadian rhythms	26
Regulation of inflammation in diabetes: From genetics to epigenomics evidence	26
Mono and dual agonists of the amylin, calcitonin, and CGRP receptors and their potential in metabolic diseases	26
Nutrient sensing in the nucleus of the solitary tract mediates non-aversive suppression of feeding via inhibition of AgRP neurons	25
The role of exercise-induced peripheral factors in sleep regulation	25
Adipose tissue macrophages: Regulators of adipose tissue immunometabolism during obesity	25
Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion	25
Neuroanatomical organization and functional roles of PVN MC4R pathways in physiological and behavioral regulations	24
Genetic loss of AMPK-glycogen binding destabilises AMPK and disrupts metabolism	24
Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism	24
Prolonged fasting drives a program of metabolic inflammation in human adipose tissue	24
LANCL1 binds abscisic acid and stimulates glucose transport and mitochondrial respiration in muscle cells via the AMPK/PGC-1α/Sirt1 pathway	24
Regulation of body weight: Lessons learned from bariatric surgery	24
Adaptive thermogenesis in brown adipose tissue involves activation of pannexin-1 channels	24
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice	24
In celebration of a century with insulin – Update of insulin gene mutations in diabetes	24
Adipocytes fail to maintain cellular identity during obesity due to reduced PPARγ activity and elevated TGFβ-SMAD signaling	24
The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR	23
Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice	23
Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling	23

17β-estradiol promotes acute refeeding in hungry mice via membrane-initiated ERα signaling	23
Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodeling	23
Muscle NAD+ depletion and Serpina3n as molecular determinants of murine cancer cachexia—the effects of blocking myostatin and activins	23
Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity	23
Disrupting the ghrelin-growth hormone axis limits ghrelin's orexigenic but not glucoregulatory actions	23
Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction	22
Roles of bone-derived hormones in type 2 diabetes and cardiovascular pathophysiology	22
Nox4 mediates skeletal muscle metabolic responses to exercise	22
Emerging diabetes therapies: Bringing back the β-cells	22
Targeting cellular senescence in metabolic disease	22
The type 2 diabetes gene product STARD10 is a phosphoinositide-binding protein that controls insulin secretory granule biogenesis	22
Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems	22
PPG neurons in the nucleus of the solitary tract modulate heart rate but do not mediate GLP-1 receptor agonist-induced tachycardia in mice	22
Brown adipocyte-specific knockout of Bmal1 causes mild but significant thermogenesis impairment in mice	22
URAT1-selective inhibition ameliorates insulin resistance by attenuating diet-induced hepatic steatosis and brown adipose tissue whitening in mice	22
NFE2L1-mediated proteasome function protects from ferroptosis	22
A transcriptional cross species map of pancreatic islet cells	22
Lactate activation of α-cell KATP channels inhibits glucagon secretion by hyperpolarizing the membrane potential and reducing Ca2+ entry	22
Specific amino acid supplementation rescues the heart from lipid overload-induced insulin resistance and contractile dysfunction by targeting the endosomal mTOR–v-ATPase axis	21
Daily running enhances molecular and physiological circadian rhythms in skeletal muscle	21
Ablation of glucokinase-expressing tanycytes impacts energy balance and increases adiposity in mice	21
Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure	21
Ketogenic diet administration to mice after a high-fat-diet regimen promotes weight loss, glycemic normalization and induces adaptations of ketogenic pathways in liver and kidney	21
FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations	21
What is a β cell? – Chapter I in the Human Islet Research Network (HIRN) review series	21
Insulin and obesity transform hypothalamic-pituitary-adrenal axis stemness and function in a hyperactive state	21
Roux-en-Y gastric bypass contributes to weight loss-independent improvement in hypothalamic inflammation and leptin sensitivity through gut-microglia-neuron-crosstalk	21
TFEB deficiency attenuates mitochondrial degradation upon brown adipose tissue whitening at thermoneutrality	20
Adipocyte CAMK2 deficiency improves obesity-associated glucose intolerance	20
Sex differences in islet stress responses support female β cell resilience	20
Structural principles of insulin formulation and analog design: A century of innovation	20
The effects of housing density on mouse thermal physiology depend on sex and ambient temperature	20
Osteocalcin and vascular function: is there a cross-talk?	20
Sensory neurons expressing calcitonin gene-related peptide α regulate adaptive thermogenesis and diet-induced obesity	20
BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice	20
Short-term inhibition of autophagy benefits pancreatic β-cells by augmenting ether lipids and peroxisomal function, and by countering depletion of n-3 polyunsaturated fatty acids after fat-feeding	20
Intestinal stem cell-derived enteroids from morbidly obese patients preserve obesity-related phenotypes: Elevated glucose absorption and gluconeogenesis	20
Upregulated ethanolamine phospholipid synthesis via selenoprotein I is required for effective metabolic reprogramming during T cell activation	20
GLP-1 and hunger modulate incentive motivation depending on insulin sensitivity in humans	20
KBP-066A, a long-acting dual amylin and calcitonin receptor agonist, induces weight loss and improves glycemic control in obese and diabetic rats	20
Wntless regulates lipogenic gene expression in adipocytes and protects against diet-induced metabolic dysfunction	20
Hepatic mTORC1 signaling activates ATF4 as part of its metabolic response to feeding and insulin	19
Chronic hyperinsulinemia promotes human hepatocyte senescence	19
Crosstalk between the muscular estrogen receptor α and BDNF/TrkB signaling alleviates metabolic syndrome via 7,8-dihydroxyflavone in female mice	19
Refeeding activates neurons in the dorsomedial hypothalamus to inhibit food intake and promote positive valence	19
Deletion of intestinal epithelial AMP-activated protein kinase alters distal colon permeability but not glucose homeostasis	19
Defective AMPK regulation of cholesterol metabolism accelerates atherosclerosis by promoting HSPC mobilization and myelopoiesis	19
Effects of ambient temperatures between 5 and 35 °C on energy balance, body mass and body composition in mice	19
Insulin-sensitizing effects of vitamin D repletion mediated by adipocyte vitamin D receptor: Studies in humans and mice	19
Translating glucose tolerance data from mice to humans: Insights from stable isotope labelled glucose tolerance tests	19
Insulin resistance per se drives early and reversible dysbiosis-mediated gut barrier impairment and bactericidal dysfunction	19
Conditional gene targeting using UCP1-Cre mice directly targets the central nervous system beyond thermogenic adipose tissues	19
Pharmacological blockade of the EP3 prostaglandin E2 receptor in the setting of type 2 diabetes enhances β-cell proliferation and identity and relieves oxidative damage	19
Indoleamine 2,3-dioxygenase mediates the therapeutic effects of adipose-derived stromal/stem cells in experimental periodontitis by modulating macrophages through the kynurenine-AhR-NRF2 pathway	19
Endothelial arginase 2 mediates retinal ischemia/reperfusion injury by inducing mitochondrial dysfunction	19
Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment?	19
Disabling MNK protein kinases promotes oxidative metabolism and protects against diet-induced obesity	18
Interaction of glucose sensing and leptin action in the brain	18
Diminished ketone interconversion, hepatic TCA cycle flux, and glucose production in D-β-hydroxybutyrate dehydrogenase hepatocyte-deficient mice	18
Dual specificity phosphatase 1 attenuates inflammation-induced cardiomyopathy by improving mitophagy and mitochondrial metabolism	18
Key features of inhibitor binding to the human mitochondrial pyruvate carrier hetero-dimer	18
Proteasome dysfunction disrupts adipogenesis and induces inflammation via ATF3	18
Activation of SIK1 by phanginin A inhibits hepatic gluconeogenesis by increasing PDE4 activity and suppressing the cAMP signaling pathway	18
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle	18
A low-carbohydrate diet induces hepatic insulin resistance and metabolic associated fatty liver disease in mice	18
Moderate SIRT1 overexpression protects against brown adipose tissue inflammation	18
Dysregulation of the Pdx1/Ovol2/Zeb2 axis in dedifferentiated β-cells triggers the induction of genes associated with epithelial–mesenchymal transition in diabetes	18
Adipocyte integrin-linked kinase plays a key role in the development of diet-induced adipose insulin resistance in male mice	17
Plasma triacylglycerols are biomarkers of β-cell function in mice and humans	17
Autocrine negative feedback regulation of lipolysis through sensing of NEFAs by FFAR4/GPR120 in WAT	17
FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice	17
BBSome ablation in SF1 neurons causes obesity without comorbidities	17
Combined genetic deletion of GDF15 and FGF21 has modest effects on body weight, hepatic steatosis and insulin resistance in high fat fed mice	17
Notum deacylates octanoylated ghrelin	17
SERPINA3C ameliorates adipose tissue inflammation through the Cathepsin G/Integrin/AKT pathway	17
Mitochondrial clearance of calcium facilitated by MICU2 controls insulin secretion	17
Disrupted liver oxidative metabolism in glycine N-methyltransferase-deficient mice is mitigated by dietary methionine restriction	17
An inhibitor-mediated beta-cell dedifferentiation model reveals distinct roles for FoxO1 in glucagon repression and insulin maturation	17
Centrally circulating α-klotho inversely correlates with human obesity and modulates arcuate cell populations in mice	17
Monitoring and modelling the dynamics of the cellular glycolysis pathway: A review and future perspectives	17
The metabolic syndrome, thiazolidinediones, and implications for intersection of chronic and inflammatory disease	17
HSP60 reduction protects against diet-induced obesity by modulating energy metabolism in adipose tissue	17
Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD)	17
Histone deacetylase 5 regulates interleukin 6 secretion and insulin action in skeletal muscle	16
Compound- and fiber type-selective requirement of AMPKγ3 for insulin-independent glucose uptake in skeletal muscle	16
Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity	16
Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones	16
Physical exercise shapes the mouse brain epigenome	16
STAT5 is required for lipid breakdown and beta-adrenergic responsiveness of brown adipose tissue	16
Histone H3K9 butyrylation is regulated by dietary fat and stress via an Acyl-CoA dehydrogenase short chain-dependent mechanism	16
Nuclear Receptor CoRepressors, NCOR1 and SMRT, are required for maintaining systemic metabolic homeostasis	16
Loss of chemerin triggers bone remodeling in vivo and in vitro	16
Neuronal miR-29a protects from obesity in adult mice	16
Sensory neurons derived from diabetic rats exhibit deficits in functional glycolysis and ATP that are ameliorated by IGF-1	16
White adipose remodeling during browning in mice involves YBX1 to drive thermogenic commitment	16